# S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

> **NCT00336947** · PHASE3 · UNKNOWN · sponsor: **Yokohama City University** · enrollment: 500 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** tegafur-gimeracil-oteracil potassium
- **DRUG:** tegafur-uracil
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00336947
- **Lead sponsor:** Yokohama City University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-04
- **Primary completion:** 2012-03
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2013-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336947, "S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00336947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*